Patient Derived Xenograft Model Market, By Model Type, By Implantation Method, By Tumor Type, By Application, By End User, By Geography

Description

Patient Derived Xenograft Model Market is estimated to be valued at USD 175.0 Mn in 2026 and is expected to reach USD 580.9 Mn by 2033, growing at a compound annual growth rate (CAGR) of 18.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 175.0 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	18.70%	2033 Value Projection:	USD 580.9 Mn

The global patient derived xenograft model market covers a broad set of model type categories, including Cell line derived models, Patient derived organoids, and Genetically engineered models and Others (Primary cell derived models, cell processed models etc.), used across applications such as Gastrointestinal Tumor Model, Gynecological Tumor Model, and Respiratory Tumor Model and Other Tumor Model. Demand is supported by adoption among Pharmaceutical & Biotechnology Companies, and Contract Research Organizations (CROs) and the need for more efficient, reliable solutions. Continued technological advancement and rising end-user requirements are shaping the growth of this market.

Market Dynamics:

Growing adoption across Gastrointestinal Tumor Model, and Gynecological Tumor Model, rising end-user demand, and a continued focus on improving efficiency and performance are major factors expected to drive growth of the global patient derived xenograft model market. A wider range of available options is making these solutions accessible to a broader base of users.

For instance, companies are expanding their portfolios to address evolving requirements across Pharmaceutical & Biotechnology Companies, and Contract Research Organizations (CROs). Moreover, increasing investment in innovation and new technology integration is expected to create new growth opportunities for market players over the forecast period.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global patient derived xenograft model market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include THE JACKSON LABORATORY, Champions Oncology, Inc, Charles River Laboratories, Crown Bioscience, Hera Biolabs, Horizon Discovery Ltd., Oncodesign, Pharmatest Services, Shanghai LIDE Biotech, Aragen Life Sciences Ltd., Creative Animodel, Urosphere, and Applied StemCell and WuXi AppTec, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global patient derived xenograft model market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global patient derived xenograft model market.

Detailed Segmentation:

Global Patient Derived Xenograft Model Market, By Model Type (Revenue, USD Bn, 2021 - 2033)
Cell line derived models
Patient derived organoids
Genetically engineered models and Others (Primary cell derived models, cell processed models etc.)
Global Patient Derived Xenograft Model Market, By Implantation Method (Revenue, USD Bn, 2021 - 2033)
Subcutaneous Implantation
Orthopedic Implantation and Others
Global Patient Derived Xenograft Model Market, By Tumor Type (Revenue, USD Bn, 2021 - 2033)
Blood Cancer Models
Solid Tumor Models
Pediatric Tumor Models
Other Rare Tumor Models
Combination PDX Models
Custom PDX Models
Others
Global Patient Derived Xenograft Model Market, By Application (Revenue, USD Bn, 2021 - 2033)
Gastrointestinal Tumor Model
Gynecological Tumor Model
Respiratory Tumor Model and Other Tumor Model
Global Patient Derived Xenograft Model Market, By End User (Revenue, USD Bn, 2021 - 2033)
Pharmaceutical & Biotechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutions
Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Company Profiles:
THE JACKSON LABORATORY*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
Champions Oncology, Inc
Charles River Laboratories
Crown Bioscience
Hera Biolabs
Horizon Discovery Ltd.
Oncodesign
Pharmatest Services
Shanghai LIDE Biotech
Aragen Life Sciences Ltd.
Creative Animodel
Urosphere
Applied StemCell and WuXi AppTec

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI6506

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Patient Derived Xenograft Model, By Model Type
- Market Patient Derived Xenograft Model, By Implantation Method
- Market Patient Derived Xenograft Model, By Tumor Type
- Market Patient Derived Xenograft Model, By End User
- Market Patient Derived Xenograft Model, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
  - Increasing Cancer Research
- Restraints
  - Limitations of PDX Models
- Opportunities
  - Applications in Immunotherapy Testing
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Patient Derived Xenograft Model Market , By Model Type, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Tumor explant models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Cell line derived models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Patient derived organoids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Genetically engineered models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Others (Primary cell derived models, cell processed models etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

5. Patient Derived Xenograft Model Market , By Implantation Method, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Subcutaneous Implantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Orthopedic Implantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)

6. Patient Derived Xenograft Model Market , By Tumor Type, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2023and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
Gastrointestinal Tumor Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
Gynecological Tumor Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
Respiratory Tumor Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
Other Tumor Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)

7. Patient Derived Xenograft Model Market , By End User, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, 2023and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
Academic & Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)

8. Patient Derived Xenograft Model Market , By Region, 2021 - 2033, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2023and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022-2033
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Model Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Implantation Method, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Tumor Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033,(US$ Mn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

THE JACKSON LABORATORY
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Champions Oncology, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Crown Bioscience
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Hera Biolabs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Horizon Discovery Group
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Oncodesign
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Pharmatest Services
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Shanghai LIDE Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Aragen Life Sciences Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Creative Animodel
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Urosphere
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Applied StemCell
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us